CURE DIREXION SHS ETF TR

Ownership history in WOLVERINE TRADING, LLC  ·  35 quarters on record

This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in DIREXION SHS ETF TR (CURE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 3,600 -900 -20.0% 0.00% $279K $78.31
2025 Q1 REDUCED 4,500 -200 -4.3% 0.00% $465K $105.49
2023 Q4 ADDED 4,700 +2,100 +80.8% 0.00% $478K $99.46
2023 Q3 REDUCED 2,600 -500 -16.1% 0.00% $230K $86.02
2023 Q3 REDUCED 3,100 -3,500 -53.0% 0.00% $274K $86.02
2023 Q2 REDUCED 6,600 -6,800 -50.7% 0.00% $641K $96.71
2023 Q2 ADDED 13,400 +9,900 +282.9% 0.00% $1.3M $96.71
2023 Q1 ADDED 3,500 +1,100 +45.8% 0.00% $326K $92.33
2023 Q1 REDUCED 2,400 -500 -17.2% 0.00% $223K $92.33
2022 Q4 REDUCED 2,900 -400 -12.1% 0.00% $333K $109.78
25 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CURE price (monthly, adj. close)
← Back to WOLVERINE TRADING, LLC Holdings